Cell potency is the number of different cell fates a single cell can still become. A fertilized zygote is totipotent — it can build the entire embryo and the extraembryonic tissue (placenta) that supports it. A few divisions later, the inner-cell-mass cells are pluripotent: they can still form any of the three germ layers (ectoderm, mesoderm, endoderm) but have permanently lost the ability to make placenta. As development proceeds, germ-layer cells commit to multipotent tissue stem cells (e.g. a hematopoietic stem cell can still make several blood cell types), which in turn commit to unipotent progenitors that make exactly one terminally differentiated cell type.
The defining rule of this hierarchy — modeled exactly here — is that differentiation is a one-way ratchet: once a cell commits to one branch, every sibling branch and everything downstream of it is permanently closed. This is why a skin stem cell can never spontaneously become a neuron, and why the counter of reachable final cell types only ever goes down, never up.
- Totipotent → whole embryo + placenta (broadest potency).
- Pluripotent → all three germ layers of the embryo proper.
- Multipotent → a limited family of related cell types within one tissue.
- Unipotent → exactly one differentiated cell type.
- Terminally differentiated → a dead end; potency is zero.
Regenerative medicine cares about this hierarchy because reprogramming a cell (e.g. induced pluripotent stem cells, iPSCs) means artificially reversing the ratchet — pushing a unipotent or terminally differentiated cell back up toward pluripotency in the lab, something that essentially never happens naturally.